---
title: "Analogues UK | from £9.80 | Sable Peptides"
description: "Analogues UK. Lowest catalogue price in this department is £9.80 for IGF-1 LR3. Cagrilintide from £25.99, Follistatin 344 from £34.99, IGF-1 LR3 from £9.80…"
canonical: https://www.sablepeptides.co.uk/category/analogues
publisher: Sable Peptides Limited (UK company 17488610)
note: Research use only. Not for human or veterinary use.
---

United Kingdom · catalogue department

# Analogues

Analogues research peptides at Sable: 6 compounds.

Analogue compounds. Research use only.

The figure is the lowest catalogue price for that compound, not a comparison with another seller. Research use only. Not a medicine.

-   [Cagrilintide](/cagrilintide-uk)From £25.99
-   [Follistatin 344](/follistatin-344-uk)From £34.99
-   [IGF-1 LR3](/igf-1-lr3-uk)From £9.80
-   [Retatrutide](/retatrutide-uk)From £23.50
-   [Semaglutide](/semaglutide-uk)From £21.49
-   [Tirzepatide](/tirzepatide-uk)From £30.00

[Shop this department](/catalogue?category=analogues) · [All prices](/uk-peptide-prices)

## Research questions

### Which compounds are in the Analogues department?

The Analogues department lists 6 items: [Cagrilintide](/learn/cagrilintide), [Follistatin 344](/learn/follistatin-344), [IGF-1 LR3](/learn/igf-1-lr3), Retatrutide, [Semaglutide](/learn/semaglutide), [Tirzepatide](/learn/tirzepatide). Each has a /ref record and vial pages. Laboratory research material only; not for use in people.

Sources: [sablepeptides.co.uk/category/analogues](https://www.sablepeptides.co.uk/category/analogues)

### What molecular-weight range does the Analogues department cover?

From Semaglutide at 4114 g/mol to IGF-1 LR3 at 9111 g/mol, using the molecular weights on file. No molecular weight is on file for Follistatin 344.

Sources: [pubchem.ncbi.nlm.nih.gov/compound/56843331](https://pubchem.ncbi.nlm.nih.gov/compound/56843331), [sablepeptides.co.uk/ref/igf-1-lr3](https://www.sablepeptides.co.uk/ref/igf-1-lr3)

### Which compounds have a CAS Registry Number on file?

5 of 6: Cagrilintide (1415456-99-3), IGF-1 LR3 (143045-27-6), Retatrutide (2381089-83-2), Semaglutide (910463-68-2), Tirzepatide (2023788-19-2). Not on file: Follistatin 344.

Sources: [sablepeptides.co.uk/ref/cagrilintide](https://www.sablepeptides.co.uk/ref/cagrilintide), [sablepeptides.co.uk/ref/igf-1-lr3](https://www.sablepeptides.co.uk/ref/igf-1-lr3), [sablepeptides.co.uk/ref/retatrutide](https://www.sablepeptides.co.uk/ref/retatrutide), [sablepeptides.co.uk/ref/semaglutide](https://www.sablepeptides.co.uk/ref/semaglutide), [sablepeptides.co.uk/ref/tirzepatide](https://www.sablepeptides.co.uk/ref/tirzepatide), [gsrs.ncats.nih.gov/](https://gsrs.ncats.nih.gov/)

### Does every compound here have a PubChem record?

No. Follistatin 344, IGF-1 LR3, Retatrutide have no single PubChem compound record, so the /ref page says so rather than quoting one. The others link to their PubChem CID.

Sources: [pubchem.ncbi.nlm.nih.gov/](https://pubchem.ncbi.nlm.nih.gov/)

### Which compounds here are cyclic or disulfide-bridged?

Cagrilintide. Ring closure restricts conformation and changes mass slightly; the cyclic-vs-linear explainer covers how.

Sources: [sablepeptides.co.uk/learn/cyclic-vs-linear-peptides](https://www.sablepeptides.co.uk/learn/cyclic-vs-linear-peptides), [doi.org/10.1016/j.cbpa.2017.02.006](https://doi.org/10.1016/j.cbpa.2017.02.006)

### Which contain D-amino acids?

None of the sequences on file in this department is marked with a D-amino acid.

Sources: [sablepeptides.co.uk/learn/d-amino-acid-substitution](https://www.sablepeptides.co.uk/learn/d-amino-acid-substitution), [doi.org/10.1021/ar00029a007](https://doi.org/10.1021/ar00029a007)

### Which carry terminal caps such as N-acetylation or a C-terminal amide?

Retatrutide, Tirzepatide, per the structures on their /ref pages. Caps change charge and expected mass.

Sources: [sablepeptides.co.uk/learn/terminal-capping-acetylation-amidation](https://www.sablepeptides.co.uk/learn/terminal-capping-acetylation-amidation), [doi.org/10.1016/0141-0229(94)90014-0](https://doi.org/10.1016/0141-0229\(94\)90014-0)

### Do any carry a lipid or PEG modification?

Yes: Cagrilintide, Retatrutide, Semaglutide, Tirzepatide. These modifications add substantial mass and change chromatographic behaviour.

Sources: [sablepeptides.co.uk/learn/lipidation-explained](https://www.sablepeptides.co.uk/learn/lipidation-explained), [sablepeptides.co.uk/learn/pegylation-explained](https://www.sablepeptides.co.uk/learn/pegylation-explained), [doi.org/10.1021/acs.jmedchem.5b00726](https://doi.org/10.1021/acs.jmedchem.5b00726)

### How are identity and purity checked for these compounds?

Each batch is released at ≥99% purity by HPLC, with identity checked by mass against the expected value for the exact structure. The certificate of analysis is available for every lot. Sable Peptides has been operating since 2019.

Sources: [sablepeptides.co.uk/quality](https://www.sablepeptides.co.uk/quality), [sablepeptides.co.uk/coa](https://www.sablepeptides.co.uk/coa), [sablepeptides.co.uk/learn/monoisotopic-vs-average-mass](https://www.sablepeptides.co.uk/learn/monoisotopic-vs-average-mass), [doi.org/10.1021/ac00253a037](https://doi.org/10.1021/ac00253a037)

### Does 99% purity mean the vial is 99% peptide by weight?

No. HPLC purity measures the share of peptide-related material that is the target; net peptide content is the share of total powder that is peptide, which also contains counter-ions and water.

Sources: [sablepeptides.co.uk/learn/purity-vs-net-peptide-content](https://www.sablepeptides.co.uk/learn/purity-vs-net-peptide-content), [doi.org/10.3724/SP.J.1123.2012.01035](https://doi.org/10.3724/SP.J.1123.2012.01035), [doi.org/10.1002/psc.951](https://doi.org/10.1002/psc.951)
